Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: Differential gene expression

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 550, Issue 1-2, 2004, Pages 109-121

  Cuendet, Muriel ^a   Liu, Xuemei ^a   Pisha, Emily ^a   Li, Yan ^a   Yao, Jiaqin ^a   Yu, Linning ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

17 EN; 17 hydroxyequilenin; 4,17 hydroxyequilenin; 4,17 OHEN; 4 hydroxyequilenin; 4 hydroxyestradiol; 4 hydroxyestrone; 4 OHE1; 4 OHE2; 4 OHEN; 6 TG; E1; E2; EN; equilenin; estradiol; estrone

Indexed keywords

17 BETA HYDROXYEQUILENIN; 4 HYDROXYEQUILENIN; 4 HYDROXYESTRADIOL; 4 HYDROXYESTRONE; 4,17 BETA HYDROXYEQUILENIN; BIOLOGICAL MARKER; CATECHOL DERIVATIVE; EQUILENIN; ESTRADIOL; ESTROGEN DERIVATIVE; ESTRONE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METALLOTHIONEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL CLONE; CELL GROWTH; CELL TRANSFORMATION; CHINESE HAMSTER; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DOWN REGULATION; ESTROGEN METABOLISM; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; METABOLITE; MOUSE; MUTAGENESIS; MUTAGENICITY; MUTATION RATE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TECHNIQUE; TUMOR GROWTH;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CRICETINAE; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EQUILENIN; ESTRADIOL CONGENERS; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HORSES; MALE; METALLOTHIONEIN; MODELS, CHEMICAL; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

CRICETINAE; CRICETULUS GRISEUS; EQUIDAE; MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 2342572775     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.02.005     Document Type: Article

References (59)

1. Vogel V.G., Yeomeans A., Higginbotham E. Clinical management of women at increased risk for breast cancer. Breast Cancer Res. Treat. 28:1993;195-210
2. Service R.F. New role for estrogen in cancer? Science. 279:1998;1631-1633
3. Colditz G.A., Hankinson S.E., Hunter D.J., Willett W.C., Manson J.E., Stampfer M.J., Hennekens C., Rosner B., Speizer F.E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl. J. Med. 332:1995;1589-1593
4. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hankinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. New Engl. J. Med. 336:1997;1769-1775
5. Lupulescu A. Estrogen use and cancer incidence: a review. Cancer Invest. 13:1995;287-295
6. Bolton J.L., Pisha E., Zhang F., Qiu S. Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11:1998;1113-1127
7. Zumoff B. Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy. Proc. Soc. Exp. Biol. Med. 217:1998;30-37
8. Steinberg K.K., Smith S.J., Thacker S.B., Stroup D.F. Breast cancer risk and duration of estrogen use - the role of study design in meta-analysis. Epidemiology. 5:1994;415-421
9. Li J.J., Li S.A. Estrogen-induced tumorigenesis in hamsters: roles for hormonal and carcinogenic activities. Arch. Toxicol. 55:1984;110-118
10. Pisha E., Liu X., Constantinou A.I., Bolton J.L. Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. Chem. Res. Toxicol. 14:2001;82-90
11. Klaunig J.E., Xu Y., Isenberg J.S., Bachowski S., Kolaja K.L., Jiang J., Stevenson D.E., Walborg E.F. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 106(S1):1998;289-295
12. Chen Y., Shen L., Zhang F., Lau S.S., van Breemen R.B., Nikolic D., Bolton J.L. The equine estrogen metabolite 4-hydroxyequilenin causes DNA single-strand breaks and oxidation of DNA bases in vitro. Chem. Res. Toxicol. 11:1998;1105-1111
13. Zhang F., Chen Y., Pisha E., Shen L., Xiong Y., van Breemen R.B., Bolton J.L. The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol. 12:1999;204-213
14. Shen L., Pisha E., Huang Z., Pezzuto J.M., Krol E., Alam Z., van Breemen R.B., Bolton J.L. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis. 18:1997;1093-1101
15. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13:2000;135-160
16. Zhang F., Swanson S.M., van Breemen R.B., Liu X., Yang Y., Gu C., Bolton J.L. Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem. Res. Toxicol. 14:2001;1654-1659
17. Kong L.Y., Szaniszlo P., Albrecht T., Liehr J.G. Frequency and molecular analysis of hprt mutations induced by estradiol in Chinese hamster V79 cells. Int. J. Oncol. 17:2000;1141-1149
18. Aaron C.S., Bolcsfoldi G., Glatt H.R., Moore M., Nishi Y., Stankowski L., Theiss J., Thompson E. Mammalian cell gene mutation assays working group report. Mutat. Res. 312:1994;235-239
19. NIH Guidelines for the Laboratory Use of Chemical Carcinogens, US Government Printing Office, Washington, DC, 1981.
20. Han X., Liehr J.G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis. 16:1995;2571-2574
21. Spink D.C., Zhang F., Hussain M.M., Katz B.H., Liu X., Hilker D.R., Bolton J.L. Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells. Chem. Res. Toxicol. 14:2001;572-581
22. Colburn N.H., Bruegge W.F., Bates J.R., Gray R.H., Rossen J.D., Kelsey W.H., Shimada T. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38:1978;624-634
23. Caruso J.A., Reiners J.J. Jr., Emond J., Shultz T., Tainsky M.A., Alaoui-Jamali M., Batist G. Genetic alteration of chromosome 8 is a common feature of human mammary epithelial cell lines transformed in vitro with benzo[a]pyrene. Mutat. Res. 473:2001;85-99
24. Manning F.C., Patierno S.R. Apoptosis: inhibitor or instigator of carcinogenesis? Cancer Invest. 14:1996;455-465
25. Liehr J.G. Hormone-associated cancer: mechanistic similarities between breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ. Health Perspect. 105(S3):1997;565-569
26. Newbold R.R., Liehr J.G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60:2000;235-237
27. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21:2000;40-54
28. Han X., Liehr J.G. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis. 15:1994;997-1000
29. Han X., Liehr J.G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54:1994;5515-5517
30. Bradley M.O., Bhuyan B., Francis M.C., Langenbach R., Peterson A., Huberman E. Mutagenesis by chemical agents in V79 Chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat. Res. 87:1981;81-142
31. McGinniss M.J., Nicklas J.A., Albertini R.J. Molecular analyses of in vivo hprt mutations in human T-lymphocytes. Part IV: studies in newborns. Environ. Mol. Mutagen. 14:1989;229-237
32. Nicklas J.A., Hunter T.C., O'Neill J.P., Albertini R.J. Molecular analyses of in vivo hprt mutations in human T-lymphocytes. Part III: longitudinal study of hprt gene structural alterations and T-cell clonal origins. Mutat. Res. 215:1989;147-160
33. McGinniss M.J., Falta M.T., Sullivan L.M., Albertini R.J. In vivo hprt mutant frequencies in T-cells of normal human newborns. Mutat. Res. 240:1990;117-126
34. Finette B.A., Sullivan L.M., O'Neill J.P., Nicklas J.A., Vacek P.M., Albertini R.J. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat. Res. 308:1994;223-231
35. Hofmann W.K., de Vos S., Tsukasaki K., Wachsman W., Pinkus G.S., Said J.W., Koeffler H.P. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood. 98:2001;787-794
36. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337
37. Goncharova E.I., Rossman T.G. A role for metallothionein and zinc in spontaneous mutagenesis. Cancer Res. 54:1994;5318-5323
38. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272
39. Duncan E.L., Reddel R.R. Downregulation of metallothionein-IIA expression occurs at immortalization. Oncogene. 18:1999;897-903
40. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331
41. Lotem J., Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood. 82:1993;1092-1096
42. Kirsch D.G., Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. J. Clin. Oncol. 16:1998;3158-3168
43. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P., Norris F., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71
44. Gowen L.C., Avrutskaya A.V., Latour A.M., Koller B.H., Leadon S.A. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science. 281:1998;1009-1012
45. Brodie S.G., Xu X., Qiao W., Li W.M., Cao L., Deng C.X. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene. 20:2001;7514-7523
46. Liao D.J., Natarajan G., Deming S.L., Jamerson M.H., Johnson M., Chepko G., Dickson R.B. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Oncogene. 19:2000;1307-1317
47. Myllyla R., Alitalo K., Vaheri A., Kivirikko K.I. Regulation of collagen post-translational modification in transformed human and chick-embryo cells. Biochem. J. 196:1981;683-692
48. Echarri A., Pendergast A.M. Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11:2001;1759-1765
49. Kaul D., Khosla V.K. Molecular basis of cholesterol feedback lesion in CNS tumours. Neurol. India. 48:2000;174-177
50. Maslinski C., Kierska D. Histamine in C3H/W mice carrying spontaneous tumors of the mammary gland. Agents Actions. 33:1991;192-194
51. Zhu Y., Lin H., Li Z., Wang M., Luo J. Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res. Treat. 69:2001;29-38
52. Vogt A., Tamura K., Watson S., Lazo J.S. Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1. J. Pharmacol. Exp. Ther. 294:2000;1070-1075
53. Russo J., Hu Y.F., Silva I.D., Russo I.H. Cancer risk related to mammary gland structure and development. Microsc. Res. Tech. 52:2001;204-223
54. Uria J.A., Ferrando A.A., Velasco G., Freije J.M., Lopez-Otin C. Structure and expression in breast tumors of human TIMP-3 a new member of the metalloproteinase inhibitor family. Cancer Res. 54:1994;2091-2094
55. Sheweita S.A., Tilmisany A.K. Cancer and phase II drug-metabolizing enzymes. Curr. Drug Metab. 4:2003;45-58
56. Ye X., Franco A.A., Santos H., Nelson D.M., Kaufman P.D., Adams P.D. Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol. Cell. 11:2003;341-351
57. Liu X., Yao J., Pisha E., Yang Y., Hua Y., van Breemen R.B., Bolton J.L. Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha. Chem. Res. Toxicol. 15:2002;512-519
58. Calaf G., Russo J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14:1993;483-492
59. Malins D.C., Holmes E.H., Polissar N.L., Gunselman S.J. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer. 71:1993;3036-3043